Capital Investment Advisors’s Dimensional US Marketwide Value ETF DFUV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$923K Sell
16,777
-30
-0.2% -$1.57K 0.01% 381
2026
Q1
$814K Buy
16,807
+1,127
+7% +$55.3K 0.01% 385
2025
Q4
$731K Sell
15,680
-380
-2% -$17.2K 0.01% 407
2025
Q3
$718K Buy
16,060
+1,227
+8% +$53.4K 0.01% 401
2025
Q2
$627K Hold
14,833
– – 0.01% 419
2025
Q1
$611K Hold
14,833
– – 0.01% 407
2024
Q4
$607K Hold
14,833
– – 0.01% 396
2024
Q3
$618K Hold
14,833
– – 0.01% 378
2024
Q2
$582K Hold
14,833
– – 0.01% 372
2024
Q1
$607K Hold
14,833
– – 0.01% 365
2023
Q4
$552K Hold
14,833
– – 0.01% 366
2023
Q3
$505K Hold
14,833
– – 0.01% 356
2023
Q2
$512K Hold
14,833
– – 0.02% 338
2023
Q1
$497K Hold
14,833
– – 0.01% 350
2022
Q4
$497K Hold
14,833
– – 0.02% 356
2022
Q3
$439K Buy
+14,833
New +$482K 0.02% 353

Other funds holding DFUV

Capital Investment Advisors's DFUV Position: Q2 2026 in Review

Capital Investment Advisors reduced its Dimensional US Marketwide Value ETF (DFUV) stake by 0.18% in Q2 2026, selling an estimated $1.57K and leaving 16,777 shares worth $923K. The position accounts for 0.01% of the portfolio, ranked #381.

Capital Investment Advisors first reported a position in DFUV in Q3 2022 and has held it in 16 quarters since. 803 funds tracked by Wall St. Rank hold DFUV as of Q2 2026.

  • Capital Investment Advisors held 16,777 shares of Dimensional US Marketwide Value ETF worth $923K as of Q2 2026.
  • Capital Investment Advisors sold 30 Dimensional US Marketwide Value ETF shares in Q2 2026, an estimated $1.57K.
  • Dimensional US Marketwide Value ETF made up 0.01% of Capital Investment Advisors's portfolio in Q2 2026, its #381 holding.
  • Capital Investment Advisors first reported a position in Dimensional US Marketwide Value ETF in Q3 2022 and has held it in 16 quarters since.
  • 803 funds tracked by Wall St. Rank held Dimensional US Marketwide Value ETF as of Q2 2026.

Based on Capital Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.